Trials / Unknown
UnknownNCT03000985
Evaluation of a Psychoeducation Program for Families Caregivers of Schizophrenic Patients : Randomized Study in Two Arms
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Centre Hospitalier Charles Perrens, Bordeaux · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The involvement of family members is crucial and improves the prognosis of psychiatric patients and reinforces therapeutic adherence and reduces the frequency of relapses. For schizophrenia, the scientific literature clearly shows that it's in the interest of the patient to offer to his family a psychoeducational program. Therapeutic education programs are now part of the recommendations of good clinical practice and in the French health through the law n ° 2009-879 of July 21, 2009 on the reform of the hospital and relating to patients, health and territories.
Detailed description
Objectives We conducted a randomized study in two groups to evaluate the impact of a psychoeducational program for caregivers. Methods 60 patients with a DSM-V diagnosis of schizophrenia and their families' caregivers are recruited. Families' caregivers are randomly assigned to receive either a 6 session psychoeducation program, or no psychoeducation. Baseline evaluations: Patients: symptomatology (PANSS), medication adherence (MARS); Families' Caregivers: Quality of Life (S-CGQoL), Burden (Zarit), knowledge of disease (KAST), therapeutic alliance (4PAS caregivers), depression (CES-D), medication adherence (CRS).
Conditions
- Schizophrenia
- Mental Disorder
- Educational Problems
- Family Relations
- Relapse
- Medication Adherence
- Psychiatric Disorder
- Psychiatric Hospitalization
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Psychoeducation | 6 session psychoeducation program with the family caregiver of schizophrenics patients. |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2020-12-01
- Completion
- 2021-12-01
- First posted
- 2016-12-22
- Last updated
- 2021-08-18
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03000985. Inclusion in this directory is not an endorsement.